Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Higher Daily Doses Of Buprenorphine Associated With Lower Urgent Health Care Utilization

Urgent health care utilization was lower among commercially insured adults with opioid use disorder (OUD) taking buprenorphine to treat OUD at doses higher than currently recommended by the U.S. Food and Drug Administration (FDA). A high dose was defined as above 16 milligrams (mg) and up to 24 mg. The FDA-recommended dose is between 8 mg and 16 mg. People with OUD who use fentanyl often need higher doses of buprenorphine.

About 12.5% of those taking buprenorphine experienced an emergency department visit or inpatient service. Those who were taking buprenorphine at doses higher than 16 mg had . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.